INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 110 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $138,000 | +3.0% | 13,683 | -26.0% | 0.00% | – |
| Q2 2018 | $134,000 | +21.8% | 18,483 | +1.4% | 0.00% | – |
| Q1 2018 | $110,000 | -63.1% | 18,233 | -41.2% | 0.00% | -100.0% |
| Q4 2017 | $298,000 | +109.9% | 31,008 | +93.5% | 0.00% | – |
| Q3 2017 | $142,000 | -6.6% | 16,026 | +33.5% | 0.00% | – |
| Q2 2017 | $152,000 | +6.3% | 12,002 | -0.9% | 0.00% | – |
| Q3 2016 | $143,000 | -61.9% | 12,116 | -8.1% | 0.00% | -100.0% |
| Q3 2015 | $375,000 | -29.6% | 13,184 | -11.1% | 0.00% | 0.0% |
| Q2 2015 | $533,000 | -15.8% | 14,831 | +36.1% | 0.00% | -33.3% |
| Q1 2015 | $633,000 | -37.1% | 10,896 | -58.0% | 0.00% | -50.0% |
| Q3 2014 | $1,006,000 | +62.0% | 25,940 | +30.5% | 0.01% | +50.0% |
| Q2 2014 | $621,000 | – | 19,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
| JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
| Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
| Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
| Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
| Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
| JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
| B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |